{
    "2021-08-31": [
        [
            {
                "time": "2021-08-31",
                "original_text": "国金证券维持华兰生物买入评级：血制品和疫苗业务下半年有望改善和放量",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "血制品",
                        "疫苗",
                        "下半年",
                        "改善",
                        "放量"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-31",
                "original_text": "5000亿“光伏茅”又飙新高！高瓴8个月赚150亿",
                "features": {
                    "keywords": [
                        "光伏",
                        "高瓴",
                        "新高",
                        "8个月",
                        "150亿"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-31",
                "original_text": "华兰生物董事长增持自家股 不排除未来继续增持",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "董事长",
                        "增持",
                        "未来",
                        "继续"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}